
Opinion|Videos|October 24, 2024
Effective Balance of Approved Therapies and Patient Preferences
Author(s)Stuart H. Isaacson, MD, FAAN
Key Takeaways
- Patient-centered care involves understanding patient values and preferences alongside clinical efficacy and safety of therapies.
- Open communication and shared decision-making empower patients to actively participate in their treatment plans.
Dr. Isaacson discusses how health care providers can effectively balance the pharmacological properties of approved therapies for Parkinson's disease with patient preferences and comfort levels by fostering open communication and individualized care approaches.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How can healthcare providers effectively balance pharmacological properties of approved therapies with patient preferences and comfort levels?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis
2
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
3
Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis
4
Using Human iPSC Models to Dissect PIRA Mechanisms in Progressive Multiple Sclerosis: Valentina Fossati, PhD
5






